SAN DIEGO--(BUSINESS WIRE)--April 21, 2006--Cytori Therapeutics, Inc. (NASDAQ:CYTX - News; Frankfurt:XMPA - News) announced today preclinical data demonstrating that adipose stem and regenerative cell-based therapy following a heart attack in pigs is not associated with an increased risk of irregular heart rhythms, which can result in potentially life threatening complications from heart attacks. The data indicate that adipose stem and regenerative cells may reduce the incidence of these potentially fatal arrhythmias. The results of the study, conducted in collaboration with Tulane University, were presented at the German Cardiac Society Annual Conference, held April 20-22, 2006 in Mannheim, Germany.
